Pathophysiology of type 2 diabetes in sub-Saharan Africans
2022/09/27 by Julia H. Goedecke, Amy E. Mendham · 25 citations
Medicine · Biochemistry, Genetics and Molecular Biology · #Diabetes, Cardiovascular Risks, and Lipoproteins #Genetic Associations and Epidemiology #Diabetes and associated disorders
paper · pdf · doi:10.1007/s00125-022-05795-2
Abstract
Sub-Saharan Africa (SSA) is the region with the highest projected rates of increase in type 2 diabetes (129% by 2045), which will exacerbate the already high prevalence of type 2 diabetes complications and comorbidities in SSA. In addition, SSA is grappling with poverty-related health problems and infectious diseases and is also undergoing the most rapid rates of urbanisation globally. These socioenvironmental and lifestyle factors may interact with genetic factors to alter the pathophysiological sequence leading to type 2 diabetes in sub-Saharan African populations. Indeed, current evidence from SSA and the diaspora suggests that the pathophysiology of type 2 diabetes in Black Africans is different from that in their European counterparts. Studies from the diaspora suggest that insulin clearance is the primary defect underlying the development of type 2 diabetes. We propose that, among Black Africans from SSA, hyperinsulinaemia due to a combination of both increased insulin secretion and reduced hepatic insulin clearance is the primary defect, which promotes obesity and insulin resistance, exacerbating the hyperinsulinaemia and eventually leading to beta cell failure and type 2 diabetes. Nonetheless, the current understanding of the pathogenesis of type 2 diabetes and the clinical guidelines for preventing and managing the disease are largely based on studies including participants of predominately White European ancestry. In this review, we summarise the existing knowledge base and data from the only non-pharmacological intervention that explores the pathophysiology of type 2 diabetes in SSA. We also highlight factors that may influence the pathogenesis of type 2 diabetes in SSA, such as social determinants, infectious diseases and genetic and epigenetic influences.
Citations
Cited by
- Association of Dietary Changes with Risk Factors of Type 2 Diabetes among Older Adults in Sharpeville, South Africa, from 2004 to 2014. [europepmc]
- Predictors of microvascular complications in patients with type 2 diabetes mellitus at regional referral hospitals in the central zone, Tanzania: a cross-sectional study. [europepmc]
- Precision nutrition for type 2 diabetes in Benin: leveraging linear goal programming to optimize diets with emphasis on adequacy, affordability, accessibility, and culture. [europepmc]
- Ethnic differences in the manifestation of early-onset type 2 diabetes. [europepmc]
- The economic burden of type 2 diabetes on the public healthcare system in Kenya: a cost of illness study. [europepmc]
- Associations of HIV and prevalent type 2 diabetes mellitus in the context of obesity in South Africa. [europepmc]
- Exploring the effects of t ime-restricted e ating on body weight and associated cardiometabolic outcomes in S outh A frican women living with HIV (TESSA): protocol for a randomised controlled trial. [europepmc]
- The evaluation of prothrombin time and activated partial thromboplastin time among diabetic and healthy controls in Africa: systematic review and meta-analysis. [europepmc]
- Microbiology and Antimicrobial Resistance Profile in Patients with Diabetic Foot Sepsis at a Central Hospital in Johannesburg, South Africa. [europepmc]
- Genome-wide association study identifying novel risk variants associated with glycaemic traits in the continental African AWI-Gen cohort. [europepmc]
- Phenotypic and Genetic Diversity in Diabetes Across Populations. [europepmc]
- Omics Approach for Personalised Prevention of Type 2 Diabetes Mellitus for African and European Populations (OPTIMA): a protocol paper. [europepmc]
- Differential Association Between Ten Indices of Insulin Resistance and End-Organ Damage in a Community of African Ancestry in Africa. [europepmc]
- SHBG, Testosterone, and Type 2 Diabetes Risk in Middle-Aged African Women: Exploring the Effect of HIV and Menopause. [europepmc]
- Diabetes prevention and treatment: a global perspective. [europepmc]
- Facilitators and Barriers to Effective Implementation of Interprofessional Care for Type 2 Diabetes in the Elderly Population of the Southern Africa Development Community: A Systematic Review. [europepmc]
- Knowledge, attitude, and quality of life among newly diagnosed type 2 diabetic patients attending diabetic clinics at Bugando Medical Centre, Mwanza, Tanzania. [europepmc]
- Prevalence of cardiometabolic diseases in Sub-Saharan Africa: a systematic review and meta-analysis. [europepmc]
- Metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes mellitus in Tanzania: prevalence and predictors. [europepmc]
- Reuniting diabetes through the islet coordinate framework. [europepmc]
- African immigrants with type 2 diabetes present with three physiologic subtypes: implications for screening, diagnosis and treatment. [europepmc]
- Lived experiences and perceptions of social support in diabetes self-management among patients, families, and friends in Ethiopia. [europepmc]
- Vitamin D and the metabolic-associated steatotic liver disease-type 2 diabetes axis: a scoping-narrative review of global evidence and emerging perspectives for Sub-Saharan Africa. [europepmc]
- Traditional diets and cultural beliefs affecting diabetes prevention and control in Africa. [europepmc]
- “Diabetes is death”: Perceptions and care experiences of people living with type 2 diabetes in urban and rural settings in Central Uganda [europepmc]
Related